ID: ALA4634392

Max Phase: Preclinical

Molecular Formula: C14H17BrN2O3

Molecular Weight: 341.21

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)CC1NC(=O)N(OCc2ccc(Br)cc2)C1=O

Standard InChI:  InChI=1S/C14H17BrN2O3/c1-9(2)7-12-13(18)17(14(19)16-12)20-8-10-3-5-11(15)6-4-10/h3-6,9,12H,7-8H2,1-2H3,(H,16,19)

Standard InChI Key:  BHWSJZYBTLUCRH-UHFFFAOYSA-N

Associated Targets(Human)

HEp-2 3859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 341.21Molecular Weight (Monoisotopic): 340.0423AlogP: 2.85#Rotatable Bonds: 5
Polar Surface Area: 58.64Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.53CX Basic pKa: CX LogP: 3.24CX LogD: 3.24
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.84Np Likeness Score: -0.19

References

1. Cho S, Kim SH, Shin D..  (2019)  Recent applications of hydantoin and thiohydantoin in medicinal chemistry.,  164  [PMID:30622025] [10.1016/j.ejmech.2018.12.066]

Source